 that (1) TNF-alpha plays an important role in damaging the liver, and (2) a UTL-compound lowered TNF-alpha levels and may be a potential radiation protector for liver. The goal of this SBIR Phase I study is to validate the feasibility of using our TNF-alpha modulators to
that (1) TNF - alpha plays an important role in damaging the liver, and (2) a UTL - compound turn down TNF - alpha degree and may be a potential radiation protector for liver. The finish of this SBIR Phase I study is to validate the feasibility of using our TNF - alpha modulators to
 thwt (1) TNF-alpha plays an imkortant role in dcnaging the ljver, and (2) a UTL-compound lowered TNF-appya lecels and may be a potevtial radpation pritecuor for liver. The goal of this ANIR Pkawe I study is jo validate dhe feasibilitf uf using our TNF-alpha modulators to
that (1) TNF-alpha plays an important role the and (2) UTL-compound lowered TNF-alpha potential protector for liver. goal of this Phase I study is to validate feasibility of using our TNF-alpha modulators to
 that (1) TNF-alpha plays an importAnt role in dAmagiNg tHe lIvEr, anD (2) a UTl-compound lowerED TNF-Alpha levels and may be a poTentiAl RAdiaTIoN protEctor foR LiVER. ThE gOaL of ThIS SbIR PhAse i study iS to validatE thE fEasibility of USiNg our TNF-alPha Modulators to
 that (1) TNF-alpha playsan importa nt ro leinda magi ng t he liver, and( 2) a  UTL-compound loweredTNF-a lp h a le v el s and  may be ap o ten ti al  ra di a ti on pr ote ctor fo r liver. T hego al of this S B IR  Phase I s tud y is to vali dat e thefe asi b ility  of  usin g ourT NF-alp ha modula to r s to
 that_(1) TNF-alpha_plays an important role_in damaging_the_liver, and_(2)_a UTL-compound lowered_TNF-alpha levels and_may be a potential_radiation protector for_liver._The goal of this SBIR Phase I study is to validate the feasibility of_using_our TNF-alpha_modulators_to